| Study group (n = 6) | Control group (n = 50) | P | Effect size |
---|---|---|---|---|
Age at surgery | 72.8 ± 11.1 (56–85) | 75.3 ± 5.3 (43–87) | 0.345a | 0.287c |
Sex (M-F) | 3F (50%), 3Â M (50%) | 29F (58%), 21Â M (42%) | 0.708b | 0.218d |
BMI | 30.5 ± 3.2 (26–35) | 29.7 ± 2.1 (23–39) | 0.409a | 0.295c |
Follow-up (months) | 33.0 ± 22.3 (9–72) | 30.0 ± 1.2 (30–32) | 0.317a | 0.189c |
Medical history and comorbidities | Diabetes: 1 (17%) Smoker: 1 (17%) Cardiovascular diseases: 1 (17%) Obesity: 3 (50%) | Diabetes: 5 (10%) Smokers: 7 (14%) Cardiovascular diseases (including hypertension): 12 (24%) Obesity: 13 (26%) Renal failure: 1 (2%) Incontinance of urine: 7 (14%) Asthma or COPD: 6 (12%) Bowel disorder: 2 (4%) | Â | Â |